Newsroom
Newsroom
Industry News
Antheia is a synthetic biology company in the business of genetically engineering microorganisms to produce commercial products....
Industry News
Antheia joined some of the industry’s most notable thought leaders at the prestigious Forbes Sustainability Leaders Summit, which gathered on September 20 in New York...
Industry News
On Thursday, the company announced it has completed its first commercial-scale fermentation run, which resulted in the production of 116,000liters of thebaine, a key ingredient...
Press Releases
Company's first full-scale fermentation run reinforces commercial viability for a robust pipeline of Biosynthetic KSMS and APIs...
Blog Posts
Antheia’s Chief Operations Officer Zack McGahey offers his perspective on the company’s most recent commercial milestone – a successful full-scale fermentation run of its first...
Industry News
Antheia is a synthetic biology company in the business of genetically engineering microorganisms to produce commercial products....
Industry News
Antheia joined some of the industry’s most notable thought leaders at the prestigious Forbes Sustainability Leaders Summit, which gathered on September 20 in New York...
Industry News
On Thursday, the company announced it has completed its first commercial-scale fermentation run, which resulted in the production of 116,000liters of thebaine, a key ingredient...
Press Releases
Company's first full-scale fermentation run reinforces commercial viability for a robust pipeline of Biosynthetic KSMS and APIs...
Blog Posts
Antheia’s Chief Operations Officer Zack McGahey offers his perspective on the company’s most recent commercial milestone – a successful full-scale fermentation run of its first...
Industry News
Drew Endy is squarely focused on the potential of redesigning organisms for useful purposes. He also acknowledges significant challenges......
Industry News
Zack McGahey was named COO and will be responsible for all operations functions as the company scales and commercializes its first products. Prior to joining...
Industry News
Antheia CEO Christina Smolke brews up new pharmaceuticals......
Industry News
Ginkgo Bioworks, a Boston-based cell-programming specialist, will deploy its high-throughput enzyme design and screening technology to help the synthetic biology firm Antheia broaden its pipeline...
Industry News
Antheia reconstructs complex biochemical pathways in yeasts to speed up production of natural product-based drugs......
Industry News
California synthetic biology firm Antheia has joined forces with Boston-based biotech company Ginkgo Bioworks to strengthen its efforts to develop and produce essential medicines to...
Blog Posts
Each year, SynBioBeta hosts the The Global Synthetic Biology Conference to showcase the latest cutting-edge developments in biology that are changing how we solve global...
Blog Posts
We continue to see the U.S. government setting policy priorities that underscore the importance of both building a robust American bioeconomy and strengthening domestic pharmaceutical...
Blog Posts
Synthetic chemistry is an essential part of drug development, opening the door for scientists to create complex small molecules with specific properties. Small molecule drugs...
Blog Posts
We’ve recently welcomed Jesse Ahrendt, our new Senior Vice President of Quality Assurance and Regulatory Affairs, who will lead our quality and regulatory efforts. He...
Blog Posts
At Antheia, we spend a lot of time talking about synthetic biology due to the nature of our work engineering yeast to produce active pharmaceutical...
Blog Posts
This year has been ripe with growth, major achievements, and opportunities to showcase who and what make Antheia the visionary business it is. Nearly eight...